Navigation Links
AbbVie Reports First-Quarter 2013 Financial Results









8.3Note: "Operational" growth reflects percentage change over the prior year excluding the impact of exchange rate fluctuations.n/m = not meaningfuln/a = not applicable AbbVie Inc.Consolidated Statements of Earnings Quarters Ended March 31, 2013 and 2012(Unaudited) (In millions, except per share data)20132012Net sales

$4,329$4,173Cost of products sold

1,1531,156Selling, general and administrative

1,2371,247Research and development

634642Acquired in-process research and development

--150Total operating cost and expenses

3,0243,195Operating earnings

1,305978Interest expense, net

66(1)Net foreign exchange (gain) loss

1510Other (income) expense, net

(15)(37)Earnings before income tax

1,2391,006Income tax expense

271123Net earnings

$968$883Diluted earnings per share

$0.60$0.56Average diluted shares outstanding1,6051,577Note:  On January 1, 2013, Abbott Laboratories distributed 1,577 million shares of AbbVie common stock to Abbott's shareholders in connection with the separation of AbbVie from Abbott.  The computation of diluted earnings per share for the quarter ended March 31, 2012 was calculated using the shares distributed on January 1, 2013.AbbVie Inc.Reconciliation of GAAP Reported to Non-GAAP Adjusted InformationQuarter Ended March 31, 2013(Unaudited) (In millions, except per share data)1.

Specified items impacted results as follows:1Q13Earnings



EPSAs reported (GAAP)$1,239$968$0.60Adjusted for specified items:Intangible asset amortization



0.06Separation costs





0.01As adjusted (non-GAAP)$1,407$1,095$0.68Intangible asset amortization reflect

Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. AbbVie Named to S&P 500 Dividend Aristocrat Index
2. AbbVie Issues Inaugural Full-Year Outlook for 2013
3. AbbVie to Present at Barclays Global Health Care Conference
4. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
5. AbbVie to Host First-Quarter Earnings Conference Call
6. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
7. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
8. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
9. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
10. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
11. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Post Your Comments:
(Date:10/1/2015)... LONDON , Oct. 1, 2015 ... affects the temporomandibular joint (TMJ), the joint connecting ... of the patient population receiving treatment for TMD ... and about 20% of the population experiences long-term ... treatment (consultation), and device is about $4.00 billion. ...
(Date:10/1/2015)... The report will be delivered in ... of order. If print or CD-Rom version purchased, ... express service. The Gastrointestinal Symptoms Partnering 2010-2015 ... symptoms partnering deals and agreements entered into by ... gastrointestinal symptoms partnering deals Top gastrointestinal symptoms deals ...
(Date:10/1/2015)... major trend driving the Respiratory Devices market is the rising ... Respiratory Device market is currently estimated to be valued as ... reach $0.999 billion by the end of 2019. The CAGR ... This escalation is developing the need to analyze, review ... market. Owing to the rapid evolution of market in the ...
Breaking Medicine Technology:Temporomandibular Disorders (TMD) and Use of Oral Appliance for Obstructive Sleep Apnea Syndrome in the United States 2Temporomandibular Disorders (TMD) and Use of Oral Appliance for Obstructive Sleep Apnea Syndrome in the United States 3Global Gastrointestinal Symptoms Partnering 2010-2015 2Global Gastrointestinal Symptoms Partnering 2010-2015 3Global Gastrointestinal Symptoms Partnering 2010-2015 4UK Respiratory Devices Market - Growth, Trends & Forecast (2015-2020) 2UK Respiratory Devices Market - Growth, Trends & Forecast (2015-2020) 3
... April 21 ImQuest BioSciences and Arisyn Therapeutics ... from the National Institutes of Health to support ... the treatment of hepatitis C virus (HCV) infection. ... and mechanism of action of ATI-0810 (Formerly PG301029) ...
... England, April 21 Circassia Ltd, a specialty,biopharmaceutical ... has,initiated a phase II clinical study of its ... builds on positive phase II results,that demonstrated the ... clinical investigations to those with allergy-associated,asthma. , ...
Cached Medicine Technology:ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent 2Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients 2
(Date:10/3/2015)... Jacksonville, FL (PRWEB) , ... October 03, 2015 , ... ... Nurse Triage Handbook: A Convenient Guide for Providers”, written by CEO Charu G. ... data and benefits of telephone nurse triage, as well as insights from the leaders ...
(Date:10/2/2015)... ... ... Volume 2 is a set of over 50 professionally designed refraction techniques made exclusively ... refraction, blur, and magnification controls. Quickly and intuitive add sleek and transparent glass ... text, logos and video footage with absolute ease. ProGlass Volume 2 is a ...
(Date:10/2/2015)... ... October 02, 2015 , ... With Hurricane Joaquin taking an ... why Amica Insurance is sharing safety tips to help gear up for ... week, with wind speeds of approximately 130 mph. Amica is sharing the following tips ...
(Date:10/2/2015)... ... 2015 , ... Blair White, Founder and CEO of Slide To Safety ... United Plan to help evacuate children and loved one’s in emergency situations, including but ... based on the time tested and long used evacuation slides that have been in ...
(Date:10/2/2015)... New York, NY (PRWEB) , ... October 02, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – will host its 20th Annual North American Educational Forum on ...
Breaking Medicine News(10 mins):Health News:TriageLogic’s Telephone Nurse Triage Handbook is Now Available 2Health News:TriageLogic’s Telephone Nurse Triage Handbook is Now Available 3Health News:Pixel Film Studios Release ProGlass Volume 2 for FCPX 2Health News:Prepare for Hurricane Joaquin with 8 Tips from Amica Insurance 2Health News:Following Recent Tragedy at Oregon School, Slide To Safety, Developer of Patented 6 Second Rapid Evacuation Slide, Is Calling For Federal Government To Act 2Health News:North American Educational Forum Celebrates 20th Anniversary 2Health News:North American Educational Forum Celebrates 20th Anniversary 3
... 21 Physicians Practice and Tucson Medical Center have ... staff more time to devote to patient care. This ... doctors in the southern Arizona area better handle the ... Through this new alliance, Tucson Medical Center will use ...
... Ga. Slices of living human brain tissue are helping ... that engulf and engorge brain cells following a stroke. , ... brain getting insufficient blood and oxygen after a stroke, says ... Schools of Medicine and Graduate Studies. , The brain uses ...
... (Jan. 21, 2009) Early attempts at islet cell ... decades before the discovery of insulin in the 1930s. ... sites best suited for hosting transplanted islet cells. Experimental ... subcutaneous tissues and gastric submucosa. However, many transplant attempts ...
... RIO DE JANEIRO, Brazil, Jan. 21 Amil,Participacoes S.A. ... Directors of the Company, in a meeting held today, ... gross amount of R$ 0.1948 per,common share, corresponding to ... be made on April 30, 2009, based on shareholders, ...
... Specialists On Call,Inc. (SOC) announced today that ... to address the accelerating demand for services in,Texas. ... neurology on-call,services to hospitals, having already managed more ... (Logo: ) ...
... to avoid most common cause of poisoning in U.S. , , ... better, you could confuse carbon monoxide (CO) poisoning with the ... a new fact sheet out to help prevent people from ... the emergency room caused each year by unintentional CO poisoning. ...
Cached Medicine News:Health News:Physicians Practice and Tucson Medical Center Partner to Improve Patient Care in Southern Arizona 2Health News:Physicians Practice and Tucson Medical Center Partner to Improve Patient Care in Southern Arizona 3Health News:Slices of living brain tissue are helping scientists identify new stroke therapies 2Health News:Slices of living brain tissue are helping scientists identify new stroke therapies 3Health News:Cell transplantation and diabetes: New sites, new devices 2Health News:Cell transplantation and diabetes: New sites, new devices 3Health News:Cell transplantation and diabetes: New sites, new devices 4Health News:Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock 2Health News:Specialists On Call Accelerating Access to Emergency Neurology On-Call Services in Texas 2
Permanent, sutureless, epicardial pacing leads...
Bipolar Ventricular Lead...
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
The Guidant Fineline II Sterox is a steroid-eluting pacing lead designed for permanent implantation for either atrial or ventricular applications....
Medicine Products: